COCP Stock | | | USD 1.73 0.01 0.57% |
Cocrystal Pharma financial indicator trend analysis is way more than just evaluating Cocrystal Pharma prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cocrystal Pharma is a good investment. Please check the relationship between Cocrystal Pharma Capital Stock and its Long Term Debt Total accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in main economic indicators.
To learn how to invest in Cocrystal Stock, please use our
How to Invest in Cocrystal Pharma guide.
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Cocrystal Pharma Capital Stock account and
Long Term Debt Total. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Cocrystal Pharma's Capital Stock and Long Term Debt Total is -0.07. Overlapping area represents the amount of variation of Capital Stock that can explain the historical movement of Long Term Debt Total in the same time period over historical financial statements of Cocrystal Pharma, assuming nothing else is changed. The correlation between historical values of Cocrystal Pharma's Capital Stock and Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Stock of Cocrystal Pharma are associated (or correlated) with its Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt Total has no effect on the direction of Capital Stock i.e., Cocrystal Pharma's Capital Stock and Long Term Debt Total go up and down completely randomly.
Correlation Coefficient | -0.07 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
The total amount of a company's capital funded by shareholders through the issue and subscription of shares.
Most indicators from Cocrystal Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cocrystal Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in main economic indicators.
To learn how to invest in Cocrystal Stock, please use our
How to Invest in Cocrystal Pharma guide.At this time, Cocrystal Pharma's
Enterprise Value Over EBITDA is relatively stable compared to the past year. As of 03/01/2025,
Enterprise Value Multiple is likely to grow to 0.39, while
Issuance Of Capital Stock is likely to drop slightly above 3.4
M.
When running Cocrystal Pharma's price analysis, check to
measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to
predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.